{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:29:27Z","timestamp":1769833767151,"version":"3.49.0"},"reference-count":37,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To compare the efficacy of 6 tumor necrosis factor\u2013\u03b1 inhibitors (TNFi) in treatment of ankylosing spondylitis (AS) at 12 weeks and 24 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We performed a systematic literature review of randomized controlled trials of TNFi in patients with active AS. We included trials that reported efficacy at 10 to 14 weeks (12\u2013week analysis) and at 24 to 30 weeks (24-week analysis). We used Bayesian network metaanalysis (NMA) to compare their relative efficacy to improve the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and C-reactive protein (CRP) level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We included 20 trials of 6 TNFi, with 43 treatment arms and 3220 participants. All TNFi were significantly better than placebo in reducing BASDAI and BASFI at 12 weeks and 24 weeks; all but certolizumab pegol (CZP) were statistically better than placebo in reducing CRP at 12 weeks; all but CZP and infliximab-dyyb (IFX biosimilar) were significantly better than placebo in reducing CRP at 24 weeks. IFX was superior to the other TNFi in decreasing BASDAI at 12 weeks, but not at 24 weeks. Excluding 1 open-label trial, there were no differences among TNFi.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Based on this NMA of clinical trials, IFX was superior to other TNFi in reducing BASDAI at 12 weeks, but sensitive to inclusion of an open-label trial, and its efficacy was diminished at 24 weeks. The analysis was limited by few direct comparison trials. Further study of relative safety and longterm effectiveness will help inform the choice of TNFi in treating active AS.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170224","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T01:10:14Z","timestamp":1516065014000},"page":"481-490","source":"Crossref","is-referenced-by-count":22,"title":["Comparative Efficacy of Tumor Necrosis Factor-\u03b1 Inhibitors in Ankylosing Spondylitis: A Systematic Review and Bayesian Network Metaanalysis"],"prefix":"10.3899","volume":"45","author":[{"given":"Runsheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"2018112909382932000_45.4.481.1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2018112909382932000_45.4.481.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.106"},{"key":"2018112909382932000_45.4.481.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1157-3"},{"key":"2018112909382932000_45.4.481.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"2018112909382932000_45.4.481.5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40261-014-0246-6","article-title":"Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis","volume":"35","author":"Migliore","year":"2015","journal-title":"Clin Drug Investig"},{"key":"2018112909382932000_45.4.481.6","first-page":"717","article-title":"Indirect comparison of anti-TNF-\u03b1 agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials","volume":"31","author":"Shu","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909382932000_45.4.481.7","doi-asserted-by":"crossref","first-page":"e3060","DOI":"10.1097\/MD.0000000000003060","article-title":"Comparative effectiveness of biologic therapy regimens for ankylosing spondylitis: a systematic review and a network meta-analysis","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine"},{"key":"2018112909382932000_45.4.481.8","doi-asserted-by":"crossref","unstructured":"Maxwell LJ Zochling J Boonen A Singh JA Veras MMS Tanjong Ghogomu E TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 2015;CD005468.","DOI":"10.1002\/14651858.CD005468.pub2"},{"key":"2018112909382932000_45.4.481.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-167"},{"key":"2018112909382932000_45.4.481.10","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2018112909382932000_45.4.481.11","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2018112909382932000_45.4.481.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"2018112909382932000_45.4.481.13","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [Internet. Accessed November 16, 2017.] Available from: handbook-5-1.cochrane.org"},{"key":"2018112909382932000_45.4.481.14","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12458724"},{"key":"2018112909382932000_45.4.481.15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"2018112909382932000_45.4.481.16","unstructured":"R core team . R: A Language and Environment for Statistical Computing. [Internet. Accessed November 16, 2017.] Available from: www.R-project.org"},{"key":"2018112909382932000_45.4.481.17","unstructured":"van Valkenhoef G Kuiper J van Valkenhoef MG . Package \u2018gemtc.\u2019 [Internet. Accessed November 16, 2017.] Available from: cran.r-project.org\/web\/packages\/gemtc\/gemtc.pdf"},{"key":"2018112909382932000_45.4.481.18","unstructured":"Plummer M . JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. [Internet. Accessed November 16, 2017.] Available from: www.r-project.org\/conferences\/DSC-2003\/Proceedings\/Plummer.pdf"},{"key":"2018112909382932000_45.4.481.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-7-200804010-00011"},{"key":"2018112909382932000_45.4.481.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.21913"},{"key":"2018112909382932000_45.4.481.21","first-page":"2030","article-title":"Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis","volume":"35","author":"Maksymowych","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909382932000_45.4.481.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2012.01734.x"},{"key":"2018112909382932000_45.4.481.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202533"},{"key":"2018112909382932000_45.4.481.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"2018112909382932000_45.4.481.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012664"},{"key":"2018112909382932000_45.4.481.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.11325"},{"key":"2018112909382932000_45.4.481.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.020875"},{"key":"2018112909382932000_45.4.481.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056747"},{"key":"2018112909382932000_45.4.481.29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.121327"},{"key":"2018112909382932000_45.4.481.30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.139261"},{"key":"2018112909382932000_45.4.481.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.23969"},{"key":"2018112909382932000_45.4.481.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket469"},{"key":"2018112909382932000_45.4.481.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu132"},{"key":"2018112909382932000_45.4.481.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"2018112909382932000_45.4.481.35","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.022582"},{"key":"2018112909382932000_45.4.481.36","doi-asserted-by":"publisher","DOI":"10.1002\/art.20852"},{"key":"2018112909382932000_45.4.481.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091042"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:09:58Z","timestamp":1570619398000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.3899\/jrheum.170224"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170224","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]}}}